Provisional Schedule

Project Team

Email enquiries

Timeline

Key events during the development of the guidance:

Date

Update

08 July 2019

As you will be aware, the Department for Health and Social Care has asked NICE to conduct an appraisal of selinexor with low-dose dexamethasone for treating refractory multiple myeloma .
Please note that following on from advice received from the company, the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in mid-February 2020. These timings are based on a request from the company to reschedule the initial date set by NICE, in order to facilitate a suitably comprehensive and robust evidence submission.

12 April 2019

As you will be aware, the Department for Health and Social Care has asked NICE to conduct an appraisal of Selinexor with low-dose dexamethasone for treating refractory multiple myeloma .
Please note that following on from advice received from the company the timelines for this appraisal have been revised.
We now anticipate that the appraisal will begin during early October 2019 when we will write to you about how you can get involved.